COVADIS Microvascular Angina Diagnostic Criteria Calculator

Clinical calculation support · Verify results before clinical use

Diagnostic criteria assessment

Assess each of the four COVADIS domains. Select the best-supported finding for the patient.

0/4Criteria met
1

Symptoms of myocardial ischemia

Effort or rest angina, or an angina equivalent such as exertional dyspnea.

2

Absence of obstructive coronary artery disease

Non-obstructive coronary arteries: stenosis below 50% and/or FFR above 0.80, assessed by CCTA or invasive coronary angiography.

The categorical assessment above determines this criterion. Numeric entries are supportive documentation and do not silently override the selected assessment.

3

Objective evidence of myocardial ischemia

Examples include ischemic ECG changes during symptoms, stress-induced ischemic ECG changes, reversible perfusion abnormalities, or stress-induced wall-motion abnormalities.

4

Evidence of impaired coronary microvascular function

Select one or more abnormal findings supported by the relevant test report.

Numeric measurements are recorded for transparency. The checkbox is the clinician-confirmed abnormal interpretation because CFR thresholds vary by measurement technique and protocol. IMR and slow-flow thresholds shown here reflect established consensus literature and should be interpreted in context.

The final criterion status is selected explicitly; checked test findings document the evidence and do not automatically determine abnormality.

—
COVADIS diagnostic assessment
Assessment incomplete
Complete the four diagnostic domains to determine the classification.
No diagnostic classification has been assigned yet.

About the COVADIS criteria

The COVADIS framework standardizes the clinical and physiological assessment of microvascular angina in patients with suspected ischemia and non-obstructive coronary arteries (INOCA).

Diagnostic domains

CriterionEvidence considered
1. Ischemic symptomsEffort/rest angina or angina equivalents such as dyspnea.
2. Non-obstructive CADLess than 50% epicardial diameter stenosis and/or FFR >0.80.
3. Objective ischemiaIschemic ECG changes or objective ischemia on functional testing.
4. Microvascular dysfunctionReduced CFR, abnormal microvascular resistance, microvascular spasm, or slow-flow evidence in established criteria.

Classification logic used

  • Definite MVA: all four criteria are present.
  • Suspected MVA: criteria 1 and 2 are present, with either criterion 3 or criterion 4 present, but not both.
  • Criteria not fulfilled: the required combination is absent.
  • Incomplete assessment: available information is insufficient to classify reliably.

The suspected/definite classification logic is based on the established COVADIS framework described in the 2018 standardization paper and subsequent guideline summaries. The 2026 update abstract confirms the four diagnostic domains; detailed revised classification wording should be checked against the full publication when accessible.

Clinical considerations

  • Interpret CFR using the validated threshold for the specific measurement technique and laboratory protocol; published thresholds vary approximately from 2.0 to 2.5.
  • An IMR of 25 or greater is commonly used as evidence of increased microvascular resistance in invasive physiology protocols.
  • Microvascular spasm requires reproduction of symptoms and ischemic ECG changes during acetylcholine testing without epicardial spasm.
  • Exclude or consider alternative explanations, including epicardial vasospasm, diffuse epicardial disease, and heart failure with preserved ejection fraction where clinically relevant.
  • This checklist supports structured assessment and does not replace comprehensive coronary functional testing or clinical judgment.

References

Ong P, Camici PG, Beltrame JF, et al. (COVADIS).International standardization of diagnostic criteria for microvascular angina. International Journal of Cardiology. 2018;250:16–20. DOI: 10.1016/j.ijcard.2017.08.068.
Ong P, Camici PG, Beltrame J, et al.2026 update on the COVADIS diagnostic criteria of international standardization for microvascular angina. International Journal of Cardiology. 2026;466:134993. DOI: 10.1016/j.ijcard.2026.134993. Ahead of print.
Vrints C, Andreotti F, Koskinas KC, et al.2024 ESC Guidelines for the management of chronic coronary syndromes. European Heart Journal. 2024;45(36):3415–3537. DOI: 10.1093/eurheartj/ehae177.
Writing Committee Members, et al.2023 AHA/ACC Guideline for the Management of Patients With Chronic Coronary Disease. Circulation. 2023. DOI: 10.1161/CIR.0000000000001168.
Clinical disclaimer: This tool is intended for healthcare professionals as a structured aid to applying published diagnostic criteria. It does not provide a definitive diagnosis independently, does not replace clinical evaluation or invasive/non-invasive coronary function testing, and should not be used as the sole basis for treatment decisions.